Dihydrocodeine Controlled Release Actavis
Land: Nýja-Sjáland
Tungumál: enska
Heimild: Medsafe (Medicines Safety Authority)
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
Dihydrocodeine hydrogen tartrate 60mg
Fáanlegur frá:
Teva Pharma (New Zealand) Limited
INN (Alþjóðlegt nafn):
Dihydrocodeine hydrogen tartrate 60 mg
Skammtar:
60 mg
Lyfjaform:
Modified release tablet
Samsetning:
Active: Dihydrocodeine hydrogen tartrate 60mg Excipient: Calcium sulfate dihydrate Copovidone Glyceryl behenate Sodium stearyl fumarate
Gerð lyfseðils:
Class C2 Controlled Drug
Framleitt af:
Saneca Pharmaceuticals AS
Ábendingar:
Dihydrocodeine Controlled Release Actavis tablets are recommended for use in the treatment of post-operative pain, and pain associated with cancer.
Vörulýsing:
Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 60 tablets - 24 months from date of manufacture stored at or below 25°C protect from light
Leyfisdagur:
2012-08-14
